- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Community Oncology Alliance Announces Launch of Accreditation Pilot for OMH
Ten oncology practices around the nation will initiate their accreditation process this year, which includes an on-site survey bu the Commission on Cancer.
The Community Oncology Alliance, a not-for-profit organization dedicated to preserving access to community cancer care, announced the pilot of a national launch of an accreditation program for the Oncology Medical Home. This accreditation program is the result of a collaborative effort with a steering committee of cancer care organizations, advocacy organizations, insurers, and the Commission on Cancer (CoC). During the first quarter of this year, ten practices will pilot accreditation standards by demonstrating their compliance with standards and guidelines for this program. This includes an on-site survey by the CoC.
Read an article on the accreditation process by the chair of the CoC in Evidence-Based Oncology:
Read the press release here: http://bit.ly/1zMzzgH
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
